Google Scholar

Pubmed

Web of Science (Publons)

Scopus

# Corresponding/senior author(s); 1 equal contribution

pending

• Stanko C, Özcan SG, Stengel S, Szymański Ł, Steube A, Fischer M, Brioli A, Schenk^# T. UV laser crosslinking uncovers novel DNA-binding pattern of CTCF. bioRxiv doi:10.1101/2025.05.12.653382
• Sahm A, Cherkasov A, Liu H, Voronov D, Siniuk K, Schwarz R, Ohlenschlaeger O, Foerste S, Bens M, Groth M, Goerlich I, Paturej S, Klages S, Braendl B, Olsen J, Bushnell P, Poulsen AB, Ferrando S, Garibaldi F, Drago DL, Tozzini ET, Mueller F-J, Fischer M, Kretzmer H, Domenici^# P, Steffensen^# JF, Cellerino^# A, Hoffmann^# S. The Greenland shark (Somniosus microcephalus) genome provides insights into extreme longevity. bioRxiv doi:10.1101/2024.09.09.611499
• Valentim IS, Romero-Expósito FJ, Schwab K, Bayar M, Riege K, Fischer M, Olmedo M, Hoffmann S, Ermolaeva^# MA. Circadian clock disruption engages the DREAM complex in suppressing cellular health. bioRxiv 10.1101/2024.06.26.600859

2025

• Skopek¹ R, Özcan¹ SG, Chmiel P, Morgner S, Schütt J, Ghazvini Zadegan F, Stanko C, Palusińska M, Maślińska-Gromadka K, Sbirkov Y, Stengel S, Fischer M, Brioli A, Zelent A, Szymański^# Ł, Schenk^# T (2025) Synergistic potential of CDK4/6 inhibitors and ATRA in non-APL AML. Br. J. Haematol.
• Holtze^# S, Demirtürk D, Ohlenschläger O, Hegele S, Siniuk K, Förste S, Raghavan V, Groth M, Bens M, Hassel N, Martel A, Lukač M, Cizelj I, Fischer M, Liu H, Hildebrandt TB, Hoffmann S, Sahm^# A (2025) The transcriptome of the olm provides insights into its evolution and gene expression. Sci. Rep. 15: 28324
• Fischer^# M, Schwarz¹ R, Riege¹ K, Förste K, Wiechens E, Schwab K, van Bömmel A, Hoffmann S (2025) p53 reveals principles of chromatin remodeling and enhancer activation. Nucl. Acids Res. 53 (11): gkaf465
• Boutelle AM, Mabene AR, Yao D, Xu h, Wang M, Tang YJ, Lopez SS, Sinha S, Demeter J, Cheng R, Benard BA, Valente LJ, Drainas AP, Fischer M, Majeti R, Petrov D, Jackson PK, Yang F, Winslow MM, Bassik MC, Attardi^# LD (2025) Integrative multiomic approaches reveal ZMAT3 and p21 as conserved hubs in the p53 tumor suppression network. Cell Death Differ.
• Omrani O, Siniuk K, Fischer^# M (2025) Protecting cell cycle integrity: enhanced start-codon stringency in mitosis. Signal Transduct. Target. Ther. 10: 34
• Wiechens E, Vigliotti¹ F, Siniuk¹ K, Schwarz R, Schwab K, Riege K, van Bömmel A, Görlich I, Bens M, Sahm A, Groth M, Sammons MA, Loewer A, Hoffmann^# S, Fischer^# M (2025) Gene regulation by convergent promoters. Nat. Genet. 57 (1): 206–217

2024

• Sahm^# A, Riege K, Groth M, Bens M, Kraus JM, Fischer M, Kestler HA, Englert C, Schaible R, Platzer¹ M, Hoffmann¹ S (2024) Hydra has mammal-like mutation rates facilitating fast adaptation despite its nonaging phenotype. Genome Res. 34 (12): 2217-2228
• Schwab K, Riege K, Coronel L, Stanko C, Förste S, Hoffmann^# S, Fischer^# M (2024) p53 target ANKRA2 cooperates with RFX7 to regulate tumor suppressor genes. Cell Death Discov. 10: 376
• Fischer^# M, Sammons^# MA (2024) Determinants of p53 DNA binding, gene regulation, and cell fate decisions. Cell Death Differ. 31 (7): 836–843
• Fischer^# M (2024) Gene regulation by the tumor suppressor p53 – The omics era. BBA Rev. Cancer 1879 (4): 189111

• Fischer^# M (2024) Genomregulation durch Tumorsuppressoren und Onkoproteine. BIOspektrum 30 (1): 123

2023

• Fischer^# M (2023) p53 and MYC-regulated squalene epoxidase as Achilles heel in colorectal cancer. Int. J. Biol. Sci. 19 (15): 4831-4832
• Kmiecik^# SW, Shi^# Q, Chen^# YG, Moormann^# J, Hildebrandt^# TM, Schade^# A, Fischer^# M, Kim^# KQ (2023) Crafting figures to describe cellular processes. Trends Biochem. Sci. 48 (6): 491-494
• Schwab K, Coronel L, Riege K, Sacramento EK, Rahnis N, Häckes D, Cirri E, Groth M, Hoffmann S, Fischer^# M (2023) Multi-omics analysis identifies RFX7 targets involved in tumor suppression and neuronal processes. Cell Death Discov. 9: 80
• Fischer^# M, Riege K, Hoffmann S (2023) The landscape of human p53-regulated long non-coding RNAs reveals critical host gene co-regulation. Mol. Oncol. 17 (7): 1263-1279
• Fischer^# M (2023) Physiological media advance cell culture experiments. Trends Biochem. Sci. 48 (2): 103-105

2022

• Fischer M, DeCaprio^# JA (2022) Chapter 17: Control of Cell Division. In: Hoffman R, et al. (Eds.) Hematology: Basic Principles and Practice, 8th edition. Elsevier, pp. 181-190
• Fischer^# M, Schade AE, Branigan TB, Müller GA, DeCaprio^# JA (2022) Coordinating gene expression during the cell cycle. Trends Biochem. Sci. 47 (12): 1009-1022
  – selected as Cover Story
• Fischer^# M, Hoffmann^# S (2022) Synthesizing genome regulation data with vote-counting. Trends Genet. 38 (12): 1208-1216
• Fischer^# M, Schwarz R, Riege K, DeCaprio JA, Hoffmann S (2022) TargetGeneReg 2.0: a comprehensive web-atlas for p53, p63, and cell cycle-dependent gene regulation. NAR Cancer 4 (1): zcac009
• Coronel¹ L, Häckes¹ D, Schwab¹ K, Riege K, Hoffmann^# S, Fischer^# M (2022) p53-mediated AKT and mTOR inhibition requires RFX7 and DDIT4 and depends on nutrient abundance. Oncogene 41 (7): 1063-1069

2021

• Kumari R, Hummerich¹ H, Shen¹ X, Fischer¹ M, Litovchick L, Mittnacht S, DeCaprio JA, Jat^# PS (2021) Simultaneous expression of MMB-FOXM1 complex components enables efficient bypass of senescence. Sci. Rep. 11: 21506
• Woodstock D, Sammons^# MA, Fischer^# M (2021) p63 and p53: collaborative partners or dueling rivals? Front. Cell Dev. Biol. 9: 701986.
• Coronel L, Riege K, Schwab K, Förste S, Häckes D, Semerau L, Bernhart SH, Siebert R, Hoffmann^# S, Fischer^# M (2021) Transcription factor RFX7 governs a tumor suppressor network in response to p53 and stress. Nucl. Acids Res. 49 (13): 7437-7456
• Fischer^# M (2021) Mice are not humans: The case of p53. Trends Cancer 7 (1): 12-14

2020

• Riege K, Kretzmer H, Sahm A, McDade SS, Hoffmann S, Fischer^# M (2020) Dissecting the DNA binding landscape and gene regulatory network of p63 and p53. eLife 9: e63266
• Sammons^1,# MA, Nguyen^1,# TT, McDade^1,# SS, Fischer^1,# M (2020) Tumor suppressor p53: from engaging DNA to target gene regulation. Nucl. Acids Res. 48 (16): 8848-8869

2019

• Schade AE, Fischer M, DeCaprio^# JA (2019) RB, p130, and p107 Differentially Repress G1/S and G2/M Genes after p53 Activation. Nucl. Acids Res. 47 (21): 11197-11208
• Uxa S, Bernhart SH, Mages CFS, Fischer M, Kohler R, Hoffmann S, Stadler PF, Engeland K, Müller^# GA (2019) DREAM and RB cooperate to induce gene repression and cell-cycle arrest in response to p53 activation. Nucl. Acids Res. 47 (17): 9087-9103
• Fischer^# M (2019) Conservation and divergence of the p53 gene regulatory network between mice and humans. Oncogene 38 (21): 4095-4109
• McDade^1,# SS, Fischer^1,# M (2019) Chapter: TP53. In: Boffetta P, Hainaut P (Eds.) Encyclopedia of Cancer, 3rd edition Elsevier, pp. 483-495

2018

• Fischer M, Dang CV, DeCaprio^# JA (2018) Chapter 17: Control of Cell Division. In: Hoffman R, et al. (Eds.) Hematology: Basic Principles and Practice, 7th edition Elsevier, pp. 176-185

2017

• Fischer^1,# M, Müller^1,# GA (2017) Cell cycle transcription control: DREAM/MuvB and RB-E2F complexes. Crit. Rev. Biochem. Mol. Biol. 52 (6): 638-662
• Fischer^# M (2017) Census and evaluation of p53 target genes. Oncogene 36 (28):3943-3956
  – selected as Editors’ Choice: The best of Oncogene 2016-2017
• Fischer^# M, Uxa S, Stanko C, Magin TM, Engeland^# K (2017) The human papillomavirus oncoprotein E7 abrogates the p53-p21-DREAM pathway. Sci. Rep. 7 (1): 2603
• Liu¹ Y, Chen¹ S, Wang S, Soares F, Fischer M, Meng F, Du Z, Lin C, Meyer CA, DeCaprio JA, Brown^# M, Liu^# SX, He^# HH (2017) Transcriptional landscape of the human cell cycle. Proc. Natl. Acad. Sci. USA 114 (13) 3473-3478

2016

• Fischer^# M (2016) p21 governs p53’s repressive side. Cell Cycle 15 (21): 2852–2853
• Fischer^# M, Grossmann P, Padi M, DeCaprio JA (2016) Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks. Nucl. Acids Res. 44 (13): 6070-6086
• Fischer M, Quaas M, Steiner L, Engeland^# K (2016) The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes. Nucl. Acids Res. 44 (1): 164-174

2015

• Fischer¹ M, Quaas¹ M, Nickel A, Engeland^# K (2015) Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex. Oncotarget 6 (39): 41402-41417
  – selected as Priority Research Article and Cover Story
• Fischer M, DeCaprio^# JA (2015) Does Arabidopsis thaliana DREAM of cell cycle control? EMBO J. 34 (15): 1987-1989

2014

• Fischer^# M, Steiner L, Engeland^# K (2014) The transcription factor p53: Not a repressor, solely an activator. Cell Cycle 13 (19): 3037-3058
• Fischer M, Quaas M, Wintsche A, Müller GA, Engeland^# K (2014) Polo-like kinase 4 transcription is activated via CRE and NRF1 elements, repressed by DREAM through CDE/CHR sites and deregulated by HPV E7 protein. Nucl. Acids Res. 42 (1): 163-180

2013

• Fischer¹ M, Grundke¹ I, Sohr¹ S, Quaas M, Hoffmann S, Knörck A, Gumhold C, Rother^# K (2013) DREAM and MMB complexes control p53- and cell cycle-dependent transcription of kinesin family member 23 (KIF23) via a CHR promoter element. Plos One 8 (5): e63187
• Chen X, Müller GA, Quaas M, Fischer M, Han N, Stutchbury B, Sharrocks^# AD, Engeland K (2013) The forkhead transcription factor FOXM1 controls cell cycle-dependent gene expression through an atypical chromatin binding mechanism. Mol. Cell. Biol. 33 (2): 227-236

2012

• Müller GA, Quaas M, Schümann M, Krause E, Padi M, Fischer M, Litovchick L, DeCaprio JA, Engeland^# K (2012) The CHR promoter element controls cell cycle-dependent gene transcription and binds the DREAM and MMB complexes. Nucl. Acids Res. 40 (4): 1561-1578
  – selected as Breakthrough Article